FindTrial
Sign In

Establishment and application of drug hypersensitivity detection platform based on virus specific T cell recognition

Establishment and application of drug hypersensitivity detection platform based on virus specific T cell recognition

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037557
Enrollment
Unknown
Registered
2020-08-28
Start date
2022-09-30
Completion date
Unknown
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

drug eruption

Interventions

Case series:Nil

Sponsors

Shanghai Skin Disease Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 8-70 years old; 2. Systematic medication history in 4 weeks.

Exclusion criteria

Exclusion criteria: People with disturbance of consciousness

Design outcomes

Primary

MeasureTime frame
relationship between drug eruption and virus;—

Countries

China

Contacts

Public ContactTan Fei

Shanghai Skin Disease Hospital

tanfeitrue@126.com+86 18017336619

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026